Walsh, Meghara K. External Entity


Sort by

Selected publications

  • Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology2017 Academic Article GET IT
    Times cited: 4